NordiQC Assessments of CD117 Immunoassays

Rasmus Røge; Michael Bzorek; Ole Nielsen; Mogens Vyberg

doi:10.1097/PAI.0000000000000714

NordiQC Assessments of CD117 Immunoassays

Appl Immunohistochem Mol Morphol. 2019 Feb;27(2):87-91. doi: 10.1097/PAI.0000000000000714.

Authors

Rasmus Røge^{1

2}, Michael Bzorek³, Ole Nielsen⁴, Mogens Vyberg^{1

2}

Affiliations

¹ Institute of Pathology, Aalborg University Hospital.
² Department of Clinical Medicine, Aalborg University, Aalborg.
³ Department of Surgical Pathology, Zealand University Hospital, Koegevej, Roskilde.
⁴ Department of Pathology, Odense University Hospital, Winslowparken, Odense City, Denmark.

PMID: 30499819
DOI: 10.1097/PAI.0000000000000714

Abstract

This paper is the number 5 in a series developed through a partnership between ISIMM and NordiQC for the purpose of reporting research assessing the performance characteristics of immunoassays in an external proficiency-testing program.

MeSH terms

Denmark
Diagnostic Tests, Routine
Gastrointestinal Neoplasms / diagnosis
Gastrointestinal Neoplasms / metabolism*
Hematopoietic Stem Cells / metabolism*
Humans
Immunoassay / methods*
Laboratory Proficiency Testing / methods*
Proto-Oncogene Proteins c-kit / metabolism*
Quality Assurance, Health Care
Quality Control

Substances

Proto-Oncogene Proteins c-kit